These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11254841)

  • 41. Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery.
    Blasco-Colmenares E; Perl TM; Guallar E; Baumgartner WA; Conte JV; Alejo D; Pastor-Barriuso R; Sharrett AR; Faraday N
    Arch Intern Med; 2009 Apr; 169(8):788-96. PubMed ID: 19398691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
    Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of platelet-altering medications on bleeding from minor oral surgery procedures.
    Partridge CG; Campbell JH; Alvarado F
    J Oral Maxillofac Surg; 2008 Jan; 66(1):93-7. PubMed ID: 18083421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of aspirin and desmopressin on platelet reactivity in patients undergoing cardiac surgery with extracorporeal circulation.
    Keyl C; Kmitta E; Kueri S; Zietak T; Trenk D
    Thromb Haemost; 2011 Jan; 105(1):113-21. PubMed ID: 21057697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Response to aspirin and clopidogrel monitored with different platelet function methods.
    Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
    Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism.
    Morawski W; Sanak M; Cisowski M; Szczeklik M; Szczeklik W; Dropinski J; Waclawczyk T; Ulczok R; Bochenek A
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):791-6. PubMed ID: 16153930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotinin.
    Ouattara A; Bouzguenda H; Le Manach Y; Léger P; Mercadier A; Leprince P; Bonnet N; Montalescot G; Riou B; Coriat P
    Eur Heart J; 2007 Apr; 28(8):1025-32. PubMed ID: 17431000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impaired anti-platelet effect of aspirin, inflammation and platelet turnover in cardiac surgery.
    Arazi HC; Doiny DG; Torcivia RS; Grancelli H; Waldman SV; Nojek C; Fornari MC; Badimon JJ
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):863-7. PubMed ID: 20233808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspirin-induced platelet inhibition in patients undergoing cardiac surgery.
    Zimmermann N; Kurt M; Winter J; Gams E; Wenzel F; Weber AA; Hohlfeld T
    Platelets; 2007 Nov; 18(7):528-34. PubMed ID: 17957569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
    Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
    J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery.
    Karabulut H; Toraman F; Evrenkaya S; Goksel O; Tarcan S; Alhan C
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):419-23. PubMed ID: 15019671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
    Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks.
    Grundmann K; Jaschonek K; Kleine B; Dichgans J; Topka H
    J Neurol; 2003 Jan; 250(1):63-6. PubMed ID: 12527994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes.
    Małek ŁA; Spiewak M; Filipiak KJ; Grabowski M; Szpotańska M; Rosiak M; Główczyńska R; Imiela T; Huczek Z; Opolski G
    Kardiol Pol; 2007 Jan; 65(1):40-5; discussion 46. PubMed ID: 17295159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
    DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
    Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation.
    Tantry US; Bliden KP; Gurbel PA
    J Am Coll Cardiol; 2005 Nov; 46(9):1705-9. PubMed ID: 16256872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
    Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
    Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.